DCLK3 and lung disorder: Although certain antibiotics, such as AMK, CFX, and IMP, demonstrate effectiveness against Mabs, only CLR has compelling clinical efficacy for the treatment of Mabs-induced pulmonary disease (Nie et al., 2014).